Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Double Dummy, Parallel Group Study to Determine the Local Equivalence of Multiple Doses of MGR001 to Advair Diskus Administered Via Oral Inhalation in Adult Asthma Patients

NCT02245672 is registered in ClinicalTrials.gov with Mylan Pharma UK Ltd. as lead sponsor.

NCT NCT02245672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Double Dummy, Parallel Group Study to Determine the Local Equivalence of Multiple Doses of MGR001 to Advair Diskus Administered Via Oral Inhalation in Adult Asthma Patients
Lead sponsor
Mylan Pharma UK Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
July 31, 2015
Enrollment
1,128 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

asthma